Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).

Bennett JJ, Adusumilli P, Petrowsky H, Burt BM, Roberts G, Delman KA, Zager JS, Chou TC, Fong Y.

FASEB J. 2004 Jun;18(9):1001-3. Epub 2004 Apr 1.

PMID:
15059970
2.

Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.

Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.

Eur J Cancer. 2005 Jan;41(2):313-22.

PMID:
15661558
3.

Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer.

Adusumilli PS, Stiles BM, Chan MK, Chou TC, Wong RJ, Rusch VW, Fong Y.

Ann Thorac Surg. 2005 Aug;80(2):409-16; discussion 416-7.

4.

Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.

Adusumilli PS, Chan MK, Chun YS, Hezel M, Chou TC, Rusch VW, Fong Y.

Cancer Biol Ther. 2006 Jan;5(1):48-53. Epub 2006 Jan 12.

5.

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.

Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.

Cancer Gene Ther. 2000 Feb;7(2):275-83.

6.

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

Aghi M, Rabkin S, Martuza RL.

J Natl Cancer Inst. 2006 Jan 4;98(1):38-50.

PMID:
16391370
7.

Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.

Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.

Cancer Gene Ther. 2006 Mar;13(3):326-34.

PMID:
16138120
8.

Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.

Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y.

Cancer Gene Ther. 2002 Nov;9(11):935-45.

9.

Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.

Petrowsky H, Roberts GD, Kooby DA, Burt BM, Bennett JJ, Delman KA, Stanziale SF, Delohery TM, Tong WP, Federoff HJ, Fong Y.

J Virol. 2001 Aug;75(15):7050-8.

10.

Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.

Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M.

J Gene Med. 2005 May;7(5):638-48.

PMID:
15754306
11.

Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase.

Stanziale SF, Petrowsky H, Joe JK, Roberts GD, Zager JS, Gusani NJ, Ben-Porat L, Gonen M, Fong Y.

Surgery. 2002 Aug;132(2):353-9.

PMID:
12219034
12.

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer.

Bennett JJ, Kooby DA, Delman K, McAuliffe P, Halterman MW, Federoff H, Fong Y.

J Mol Med (Berl). 2000;78(3):166-74.

PMID:
10868479
13.

Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.

Mullerad M, Bochner BH, Adusumilli PS, Bhargava A, Kikuchi E, Hui-Ni C, Kattan MW, Chou TC, Fong Y.

J Urol. 2005 Aug;174(2):741-6.

15.

Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of gamma34.5-mediated virulence.

Kanai R, Tomita H, Shinoda A, Takahashi M, Goldman S, Okano H, Kawase T, Yazaki T.

Gene Ther. 2006 Jan;13(2):106-16.

PMID:
16163378
17.

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.

Schwartz GK, Farsi K, Maslak P, Kelsen DP, Spriggs D.

Clin Cancer Res. 1997 Sep;3(9):1467-72.

18.

[Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].

Zhao GZ, Tan WL, Zheng SB, Wu YD, Xie Y, Zhu WH.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1623-5, 1628. Chinese.

PMID:
17121717
19.

Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.

Ko JC, Tsai MS, Weng SH, Kuo YH, Chiu YF, Lin YW.

Toxicol Appl Pharmacol. 2011 Sep 15;255(3):327-38. doi: 10.1016/j.taap.2011.07.012. Epub 2011 Jul 24.

PMID:
21810436
20.

Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway.

Eisenberg DP, Carpenter SG, Adusumilli PS, Chan MK, Hendershott KJ, Yu Z, Fong Y.

Surgery. 2010 Aug;148(2):325-34. doi: 10.1016/j.surg.2010.05.005.

PMID:
20633729

Supplemental Content

Support Center